Scientific Advisory Board

  •   Dr Ajai Puri

    Dr Ajai Puri
    Chairman

    Ajai Puri holds a Ph.D. in Food Science from the University of Maryland and an MBA from the Crummer Business School, Rollins College.  Ajai is a member of the Supervisory Board of Nutreco N.V., additionally he serves as an Independent Non-Executive Director on the Board of Britannia Industries Limited.  As Executive Board Member and President -Research, Development and Product Integrity at Royal Numico (2003 -07), Ajai was responsible for developing and implementing a highly successful science-driven, consumer-led R & D strategy in the areas of infant nutrition and medical nutrition. Ajai had a long career at The Minute Maid Company / The Coca-Cola Company in the US. During his 22 year career with the Company, he held  a variety of positions including that of Senior Vice President Technical (Science andTechnology). At Coca-Cola he was instrumental in developing the health and wellness beverage platform, central to juice beverages as carriers of nutrition.
  •   David Sinclair PhD

    David Sinclair PhD
    Sub-Committee

    David A. Sinclair, Ph.D. is a tenured professor at Harvard Medical School, co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging, a Senior Scholar of the Ellison Medical Foundation, an honorary professor at Sydney University, and cofounder and co-chief editor of the scientific journal Aging. He has co-founded a variety of companies in the biotech and consumer health arena including Genocea and Sirtris Pharmaceuticals. He is currently a board member and investor in Segterra, a web-based healthcare company.

  •   Leodevico (Vic) Ilag

    Leodevico (Vic) Ilag
    Sub-Committee

    Vic has more than 17 years of biotech experience in the discovery and development of biologics and diagnostics.  He has served in multiple senior management roles in R&D and business development with several biotech companies in Australia and Europe including Patrys Ltd, HealthLinx Ltd (formerly Cryptome Pharmaceuticals), Xerion Pharmaceuticals and Morphosys.  He is also an advisor to other biotech companies.  Vic has a PhD in Microbiology/Immunology and did postdoctoral studies in structural biology.

  •